SCHEMBL3258562

SCHEMBL3258562

CCCCCOc1ccc(NC(=O)N(S)C(=O)c2cncc(CN3CCOCC3)c2)cc1C(F)(F)F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 2/20 0.44
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
TP53 P04637 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
RAF1 P04049 4/20 0.41
CYP2C9 P11712 1/20 0.41
BRAF P15056 6/20 0.40
ARAF P10398 1/20 0.40
MAPK14 Q16539 2/20 0.40
EGFR P00533 2/20 0.40
KDR P35968 2/20 0.40
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
HIF1A Q16665 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3258557 0.85 MAPK1 (0.51) S1PR1NPC1HPGDRAB9AKMT2A
SCHEMBL3260301 0.76 S1PR1 (0.49) S1PR1MEN1KMT2ACYP2C9RET
SCHEMBL3257407 0.75 S1PR1 (0.50) S1PR1MEN1KMT2ARAF1CYP2C9
SCHEMBL3257536 0.75 S1PR1 (0.49) S1PR1MEN1KMT2ACYP2C9RET
SCHEMBL3258245 0.74 S1PR1 (0.49) S1PR1MEN1NPC1TP53HPGD
SCHEMBL3258918 0.74 S1PR1 (0.50) S1PR1NPC1TP53TSHRRAB9A
SCHEMBL3141975 0.73 HIF1A (0.54) S1PR1NPC1HPGDRAB9AKMT2A
SCHEMBL4518245 0.72 S1PR1 (0.50) S1PR1MEN1NPC1TP53TSHR
SCHEMBL2866482 0.72 S1PR1 (0.51) S1PR1MEN1RAB9AKMT2ASMN1; SMN2
SCHEMBL2867506 0.70 S1PR1 (0.44) S1PR1NPC1RAB9AKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1747196-B1 SUBSTITUTED ARYL ACYLTHIOUREAS AND RELATED COMPOUNDS; INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS INC (US) 2010-02-10 EP claimed